 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sanara MedTech appoints Jake Waldrop as COO and Tyler Palmer as chief corporate development and strategy officer...

Sanara MedTech appoints Jake Waldrop as COO and Tyler Palmer as chief corporate development and strategy officer

FORT WORTH, TX, April 05, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ( Sanara, the Company, we, our or us ) (NASDAQ: SMTI), a medical...

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call Transcript March 26, 2024
Sanara MedTech Inc. isnt one of the 30 most popular stocks among hedge funds at the end of the third quarter...

Sanara MedTech Inc. (NASDAQ:SMTI) Q4 2023 Earnings Call Transcript

This price move could indicate a change in the trend, and may be a buy signal for investors...

Sanara MedTech (SMTI, $37.3) price moved above its 50-day Moving Average on March 27, 2024

This indicator may be signaling SMTI's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Sanara MedTech (SMTI, $37.3) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024

Q4 2023 Sanara Medtech Inc Earnings Call Transcript

Sanara MedTech (NASDAQ:SMTI  Get Free Report) had its price target dropped by Cantor Fitzgerald from $49.00 to $44.00 in a research note issued to investors on Wednesday, Benzinga reports. The...

Cantor Fitzgerald Trims Sanara MedTech (NASDAQ:SMTI) Target Price to $44.00

Despite Increased SG&A and R&D Expenses, Company Sees 42% Revenue Increase and Improved Adjusted EBITDARelated Stocks: SMTI...

Sanara MedTech Inc (SMTI) Reports Strong Sales Growth and Reduced Net Loss for Full Year 2023

FORT WORTH, TX, March 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ( Sanara, the Company, we, our or us ) (NASDAQ: SMTI), a medical...

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results

Sanara MedTech (SMTI, $37.24) entered Uptrend as Momentum indicator ascends above 0 level on Mar 19, 2024

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Volume (M)	1,263.00
52-Wk High	$48.41
52-Wk Low	$26.06

SMTI Sanara MedTech Inc

About

Feed

News

Sentiment

Earnings

Fundamentals